A 17-year-old Aboriginal girl living in a remote Northern Territory community has a history of acute rheumatic fever and now has echocardiographic evidence of rheumatic mitral regurgitation. She weighs 60 kg and has no penicillin allergy. According to current Australian rheumatic heart disease guidelines, what is the most appropriate secondary prophylaxis regimen?